HK1037861A1 - Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention - Google Patents

Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention

Info

Publication number
HK1037861A1
HK1037861A1 HK01106351A HK01106351A HK1037861A1 HK 1037861 A1 HK1037861 A1 HK 1037861A1 HK 01106351 A HK01106351 A HK 01106351A HK 01106351 A HK01106351 A HK 01106351A HK 1037861 A1 HK1037861 A1 HK 1037861A1
Authority
HK
Hong Kong
Prior art keywords
prevention
mucosae
formulations
skin
treatment
Prior art date
Application number
HK01106351A
Other languages
English (en)
Inventor
Michel G Bergeron
Andre Desormeaux
Rabeea F Omar
Julianna Juhasz
Original Assignee
Infectio Recherche Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002257001A external-priority patent/CA2257001A1/en
Application filed by Infectio Recherche Inc filed Critical Infectio Recherche Inc
Publication of HK1037861A1 publication Critical patent/HK1037861A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00—Medical syringes, e.g. enemata; Irrigators
    • A61M3/02—Enemata; Irrigators
    • A61M3/0233—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs
    • A61M3/0254—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped
    • A61M3/0262—Enemata; Irrigators characterised by liquid supply means, e.g. from pressurised reservoirs the liquid being pumped manually, e.g. by squeezing a bulb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00—Medical syringes, e.g. enemata; Irrigators
    • A61M3/02—Enemata; Irrigators
    • A61M3/0279—Cannula; Nozzles; Tips; their connection means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/10—Trunk
    • A61M2210/1042—Alimentary tract
    • A61M2210/1067—Anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/14—Female reproductive, genital organs
    • A61M2210/1475—Vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
HK01106351A 1998-04-21 2001-09-07 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention HK1037861A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2235427 1998-04-21
CA002257001A CA2257001A1 (en) 1998-12-23 1998-12-23 Method and formulations for prevention of infection of mucosae and/or skin and development of a vaginal/ano-rectal applicator for the delivery of topical formulations
PCT/CA1999/000359 WO1999053897A2 (en) 1998-04-21 1999-04-21 Topical formulation comprising poloxamers and further microbicides, and an applicator

Publications (1)

Publication Number Publication Date
HK1037861A1 true HK1037861A1 (en) 2002-02-22

Family

ID=25680156

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01106351A HK1037861A1 (en) 1998-04-21 2001-09-07 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention

Country Status (22)

Country Link
US (2) US6500460B1 (ru)
EP (2) EP1769821A1 (ru)
JP (1) JP4665075B2 (ru)
KR (1) KR20010042875A (ru)
CN (2) CN100396344C (ru)
AR (1) AR018194A1 (ru)
AT (1) ATE355050T1 (ru)
AU (1) AU762461B2 (ru)
BR (1) BR9909801A (ru)
DE (1) DE69935325T2 (ru)
ES (1) ES2284250T3 (ru)
HK (1) HK1037861A1 (ru)
HU (1) HUP0101507A3 (ru)
ID (1) ID26791A (ru)
IL (1) IL139173A0 (ru)
NO (1) NO20005310L (ru)
NZ (1) NZ507609A (ru)
PL (1) PL344111A1 (ru)
RU (1) RU2224503C2 (ru)
SK (1) SK15822000A3 (ru)
TR (2) TR200102067T2 (ru)
WO (1) WO1999053897A2 (ru)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200102067T2 (tr) * 1998-04-21 2002-06-21 Infectio Recherche Inc. Topikal formülasyonların mukoza boşluğuna verilmesi için aplikatör
US6835717B2 (en) * 2000-03-08 2004-12-28 The Johns Hopkins University School Of Medicine β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
US7465295B2 (en) 2000-10-20 2008-12-16 Bergeron Michel G Applicator for the delivery of topical formulations into mucosal cavities
WO2004026255A2 (en) * 2002-09-20 2004-04-01 La Jolla Biosciences Compositions and methods for preventing infection
US20060166941A1 (en) * 2003-03-14 2006-07-27 Epistem Limited Treatment and/or prevention of non-viral epithelial damage
DE10328942A1 (de) * 2003-06-27 2005-01-27 Lts Lohmann Therapie-Systeme Ag Transmukosale Darreichungsformen mit verminderter Schleimhautirritation
CN1311873C (zh) * 2004-06-30 2007-04-25 上海复康医药科技发展有限公司 一种温度敏感的阴道用原位凝胶制剂
US20060127459A1 (en) * 2004-12-15 2006-06-15 Lei Huang Urogenital infection inhibition
US7745158B2 (en) * 2005-12-14 2010-06-29 Kimberly-Clark Worldwide, Inc. Detection of secreted aspartyl proteases from Candida species
US20070134747A1 (en) * 2005-12-14 2007-06-14 Kimberly-Clark Worldwide, Inc. Detection of secreted lipase proteins from Candida species
CN100463675C (zh) * 2007-01-29 2009-02-25 高章圈 一种可溶性缓释外用避孕药
US20080269205A1 (en) * 2007-04-27 2008-10-30 Ondine International, Ltd. Methods to prevent vertical transmission of infectious diseases
DE102008006416A1 (de) * 2008-01-28 2009-07-30 Mayer, Thomas, Dr. med. Clindamycin zur Verwendung bei der Behandlung oder Vorbeugung der bakteriellen Vaginosis
US8591961B2 (en) 2008-09-04 2013-11-26 Allergan, Inc. Aesthetic treatment of scars and aging skin
US8308678B2 (en) * 2008-09-23 2012-11-13 Mcneil-Ppc, Inc. Pre-filled applicator device
US8236768B2 (en) 2008-10-03 2012-08-07 3B Pharmaceuticals, Inc. Topical antiviral formulations
US9662481B2 (en) 2008-10-07 2017-05-30 Cristcot Llc Method and apparatus for inserting a rectal suppository
US8192393B2 (en) 2008-10-07 2012-06-05 Christcot Medical Company Method and apparatus for inserting a rectal suppository
WO2011109469A1 (en) * 2010-03-03 2011-09-09 Neocutis Sa Compositions and methods for treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
JP2013538231A (ja) 2010-09-17 2013-10-10 ブラッシカ プロテクション プロダクツ リミテッド ライアビリティ カンパニー グルコシノレートによる処置のための製剤
CA2888778C (en) 2012-10-19 2021-01-12 Cristcot Inc. Suppository insertion device, suppository, and method of manufacturing a suppository
EP3013368A1 (en) 2013-06-25 2016-05-04 Mission Pharmacal Company Novel formulations for the treatment of vaginal disorders
KR20240110074A (ko) * 2014-07-07 2024-07-12 엘리안 엘엘씨 바이러스 예방 치료 방법 및 노출-전 예방 키트
US11071745B2 (en) 2014-07-07 2021-07-27 Elian Llc Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
WO2016112388A1 (en) 2015-01-10 2016-07-14 Nine Medical, Inc. Methods and devices to prevent premature birth
US11298515B2 (en) 2016-05-12 2022-04-12 Cristcot Llc Single-use suppository insertion device and method
ITUA20164065A1 (it) * 2016-06-01 2017-12-01 Probiotical Spa Composizioni in gel per applicazioni topiche a base di batteri, preparazione delle stesse e loro usi.
EP3532020B1 (en) * 2016-10-28 2023-03-29 Rb Health (Us) Llc Feminine hygiene products
CN107224663B (zh) * 2017-07-21 2019-12-03 新乡医学院第一附属医院 一种泌尿外科用尿道给药器
MX2021002833A (es) 2018-09-27 2021-05-27 Biophysics Pharma Inc Sistema de suministro de farmaco transdermico.
CN110624173B (zh) * 2019-10-12 2022-02-08 南通大学附属医院 一种无创妇科护理用药装置
CN115040501B (zh) * 2022-06-06 2023-09-12 中国中医科学院广安门医院 顺-13-十八碳烯酸或其盐化合物在制备促进受损皮肤和/或黏膜愈合的药物中的应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US563349A (en) * 1896-07-07 Wash boiler attachment
US2683456A (en) * 1953-03-02 1954-07-13 Louis A Pierson Rectal medicator
DE3324780A1 (de) * 1983-07-08 1985-01-17 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Vorrichtung zur intra-analen applikation von fluessigen oder pastoesen wirkstoffzubereitungen
DE3441609A1 (de) * 1984-11-14 1986-05-22 Bramlage Gmbh, 2842 Lohne Salbenapplikator
DE3513645A1 (de) * 1985-04-16 1986-10-16 Dr. Kade Pharmazeutische Fabrik GmbH, 1000 Berlin Applikator fuer haemorrhoidalsalben
FR2585575B1 (fr) * 1985-08-01 1989-03-03 Pf Medicament Compositions pharmaceutiques a activite keratolytique sous forme de gel comportant de l'acide salicylique hydro-alcoolique
US5057310A (en) * 1986-11-06 1991-10-15 Hill Ira D Method of manufacturing oral hygiene preparations containing active SnF.sub.
JPS63253026A (ja) * 1987-04-10 1988-10-20 Masahiko Ito エイズ・ウイルス増殖抑制剤
US4980152A (en) * 1987-08-06 1990-12-25 Marion Laboratories Oral preparation
JPH0624498B2 (ja) 1987-11-30 1994-04-06 ▲ひろ▼陸 佐藤 噴射装置の噴射ノズル
US5098711A (en) * 1988-11-14 1992-03-24 Ira Hill Method of treating the oral cavity with dental floss containing chemotherapeutic agents
EP0386960A3 (en) * 1989-03-07 1991-10-23 American Cyanamid Company Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
US5298260A (en) * 1990-05-01 1994-03-29 Mediventures, Inc. Topical drug delivery with polyoxyalkylene polymer thermoreversible gels adjustable for pH and osmolality
US5593683A (en) * 1990-05-01 1997-01-14 Mdv Technologies, Inc. Method of making thermoreversible polyoxyalkylene gels
US5185153A (en) * 1990-10-04 1993-02-09 The Research Foundation Of The State University Of New York Agents effecting the lysis of oral bacteria
ES2101850T3 (es) * 1991-06-20 1997-07-16 Viro Tex Corp Composicion topica que potencia la curacion de lesiones de herpes.
AT408191B (de) 1991-08-19 2001-09-25 Haemosan Erzeugung Pharmazeuti Verfahren zur inaktivierung von prionen
US5260066A (en) * 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
CN2171372Y (zh) * 1993-03-13 1994-07-13 谭运江 直肠液体注药器
CN1054504C (zh) * 1993-03-15 2000-07-19 科尔加特·帕尔莫利弗公司 洁牙剂
CN2183786Y (zh) * 1993-10-22 1994-11-30 盖国忠 双腔肛点器
US5424060A (en) * 1993-10-25 1995-06-13 Church & Dwight Co., Inc. Dentifrice composition containing stabilized sodium percarbonate
US6203803B1 (en) * 1994-12-14 2001-03-20 Societe L'oreal S.A. Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained
ES2153485T3 (es) * 1994-07-13 2001-03-01 Alza Corp Composicion y procedimiento que incrementa la difusion percutanea por electrotransporte de una substancia.
DE69509554T2 (de) * 1994-12-06 1999-12-23 The Procter & Gamble Co., Cincinnati Lagerbeständige flüssige hautreinigungszusammensetzung mit gelbindenden polymeren, lipiden und athylenglykolfettsäureestern
US5624906A (en) * 1994-12-08 1997-04-29 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds
DE19530879A1 (de) * 1995-08-10 1997-02-13 Schuelke & Mayr Gmbh Vorrichtung zum Aufbringen von Medikamentenflüssigkeit auf Schleimhäute in Körperhöhlungen
AU723081B2 (en) * 1996-05-09 2000-08-17 Infectio Recherche Inc. Formulation for use in the prevention of pathogen induced diseases including HIV and HSV
US6191165B1 (en) * 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
US5908612A (en) * 1996-12-31 1999-06-01 Basf Corporation Oral care compositions comprising liquid polyoxyalkylene compounds as solubilizers/gelling agents
US5843043A (en) * 1997-03-25 1998-12-01 Markus; George Syringe and process for dispensing treatment fluid
US5843471A (en) * 1997-11-06 1998-12-01 Chaykin; Sterling Oral cleansing: methods and compositions
CN1171635C (zh) * 1998-03-07 2004-10-20 株式会社大熊制药 含有人表皮生长因子的局部用组合物
DE29807045U1 (de) * 1998-04-18 1998-06-25 Jakoubek Medizintechnik Gmbh, 78576 Emmingen-Liptingen Flexible Katheder-Hülsenführung
TR200102067T2 (tr) * 1998-04-21 2002-06-21 Infectio Recherche Inc. Topikal formülasyonların mukoza boşluğuna verilmesi için aplikatör
NZ531785A (en) * 2001-08-20 2007-03-30 Maiken Nedergaard Treatment of glial tumors with ionotropic glutamate receptor antagonists

Also Published As

Publication number Publication date
US20030133969A1 (en) 2003-07-17
AU3590499A (en) 1999-11-08
US6500460B1 (en) 2002-12-31
SK15822000A3 (sk) 2001-08-06
BR9909801A (pt) 2002-01-22
HUP0101507A3 (en) 2002-10-28
KR20010042875A (ko) 2001-05-25
NZ507609A (en) 2003-09-26
TR200003074T2 (tr) 2001-01-22
WO1999053897A3 (en) 2000-04-13
PL344111A1 (en) 2001-10-08
WO1999053897A2 (en) 1999-10-28
TR200102067T2 (tr) 2002-06-21
NO20005310D0 (no) 2000-10-20
EP1769821A1 (en) 2007-04-04
HUP0101507A2 (hu) 2002-03-28
IL139173A0 (en) 2001-11-25
CN1302215A (zh) 2001-07-04
AU762461B2 (en) 2003-06-26
ATE355050T1 (de) 2006-03-15
CN100396344C (zh) 2008-06-25
NO20005310L (no) 2000-12-21
CN1597008A (zh) 2005-03-23
CN100374110C (zh) 2008-03-12
DE69935325D1 (de) 2007-04-12
ES2284250T3 (es) 2007-11-01
ID26791A (id) 2001-02-08
JP2002512180A (ja) 2002-04-23
DE69935325T2 (de) 2007-11-15
EP1079802A2 (en) 2001-03-07
RU2224503C2 (ru) 2004-02-27
AR018194A1 (es) 2001-10-31
JP4665075B2 (ja) 2011-04-06
US7192607B2 (en) 2007-03-20
EP1079802B1 (en) 2007-02-28

Similar Documents

Publication Publication Date Title
HK1037861A1 (en) Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention
HK1022439A1 (en) Pharmaceutical compositions containing lactobacilli for treatment fo vaginal infections
AU1773600A (en) Topical treatment of skin disease
HUP9904317A3 (en) Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases
HUP0104963A3 (en) Compositions for the treatment of skin diseases
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
IT1290781B1 (it) Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
MXPA01003761A (es) Agente para tratar oftalmopatia.
GB2354944B (en) Skin treatment compositions
AU2002215187A1 (en) S-adenosylmethionine and derivatives thereof for the treatment and prevention ofalzheimer's disease
ZA991231B (en) Skin care compositions.
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
GB9510162D0 (en) Compositions for the treatment of skin conditions
EP1107778A4 (en) TREATMENT OF DISEASE CONDITIONS
AU1022501A (en) Use of compositions for the caring treatment of the skin
ZA991783B (en) Therapeutic treatment for autoimmune diseases.
AU3061199A (en) Skin treatment compositions and the use thereof
HUP0000569A3 (en) Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
HU9700079D0 (en) Topical compositions for the treatment of skin disease
AU3827199A (en) Use of antioxidants for the treatment of inflammatory skin diseases
ZA9610264B (en) Preparation for use in the treatment of skin disorders.
PL350327A1 (en) Compositions for the treatment of skin diseases
EP0998934A4 (en) REMEDIES AGAINST INTRAMEDULLARY DISEASES
HU9800835D0 (en) Pharmaceutical composition for treatment diseases causing by ascophaera apis
GC0000176A (en) Pharmaceutical combination preparations for the treatment of cardiac disorders

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110421